When was Membio founded?

Membio was founded in 2018 and raised its 1st funding round within a year of its incorporation.

Where is Membio located?

Membio is headquartered in Kitchener, Canada.

Who is the current CEO of Membio?

Shane Kilpatrick of Membio. They have also founded 1 company.

How many employees does Membio have?

As of Jul 01, 2024, the latest employee count at Membio is 13.

Is Membio a funded company?

Membio is a funded company, having raised a total of $280K across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Dec 22, 2018.

When was the latest funding round of Membio?

Membio's latest funding was a $***** Seed round on Nov 01, 2019, with participation from 1 investor.

Where does Membio rank among its competitors?

Membio ranks 5th amongst 49 active competitors, of which 10 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Culture Biosciences, which secured an undisclosed amount in Dec, 2025.

Who are the top competitors of Membio?

Membio's top competitors include Culture Biosciences, PBS Biotech and Bionet Engineering. Among them, Culture Biosciences secured the most recent funding round in December, 2025.

Membio - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of single-use bioreactors for cell and gene therapies. The company offers single-use benchtop bioreactor system which uses a proprietary design that ensures a consistent environment for cells at every scale.

Website: membio.ca
Social
Email ID: *****@membio.ca, *****@membio.ca
Phone Number: +1 **********

Key Metrics

Founded Year

2018

Location

Kitchener, Canada

Stage

Seed

Total Funding

$280K in 3 rounds

Latest Funding Round

Seed, Nov 01, 2019, $*****

Investors

Accelerator Centre & 8 more

Ranked

5^th among 49 active competitors

Employee Count

13 as on Jul 01, 2024

Similar Companies

Culture Biosciences & 58 more

View Membio's full profile

Membio has raised a total funding of $280K over 3 rounds. Its first funding round was on Dec 22, 2018. Its latest funding round was a Seed round on Nov 01, 2019 for $*****. 1 investor participated in its latest round. Membio has 9 institutional investors.

Here is the list of recent funding rounds of Membio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 01, 2019	3117678	Seed	5153645	6204462	9586404	4614232
Feb 11, 2019	1106769	Seed	3864015	1932811	6239603	2949356
Dec 22, 2018	4923640	Grant (prize money)	4811839	4914299	3650861	Velocity

Access funding benchmarks and valuations. Sign up today!

View details of Membio's funding rounds and investors

The founders of Membio are Megan Logan, Shane Kilpatrick, Andrew Greenstreet and Andrew Pundsack. Shane Kilpatrick is the CEO of Membio.

Here are the details of Membio's key team members:

Megan Logan: Co-Founder of Membio and founder of 1 other company.
Shane Kilpatrick: Founder & CEO of Membio and founder of 1 other company.
Andrew Greenstreet: CTO & Cofounder of Membio.
Andrew Pundsack: Bioreactor Design Lead | Co-Founder of Membio.

View details of Membio's Founder profiles and Board Members

Membio's employee count trend

Membio has 13 employees as of Jul 24. Here is Membio's employee count trend over the years:

Uncover Membio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Membio include Culture Biosciences, PBS Biotech and Bionet Engineering. Here is the list of Top 10 competitors of Membio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Culture Biosciences 2016, San Francisco (United States), Series C	Provider of biomanufacturing hardware and software tools for research purposes	$107M	Northpond Ventures, Cultivian Sandbox & 22 others	69/100
2nd	PBS Biotech 2006, Camarillo (United States), Series B	Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies	$70.2M	Avego, CYwP Funds & 2 others	56/100
3rd	Bionet Engineering 1999, Santiago Papasquiaro (Mexico), Unfunded	Provider of products and services for bioprocess engineering	-	-	48/100
4th	MicroBiopharm Japan 2011, Tokyo (Japan), Acquired	Provides discovery and contract research services to the biopharma companies	$124K	Toray Industries, T Capital Partners	47/100
5th	Membio 2018, Kitchener (Canada), Seed	Developer of single-use bioreactors for cell and gene therapies	$280K	McNamara Family Investments, True Ventures ... & 7 others	40/100
6th	m2p-labs 2005, Baesweiler (Germany), Acquired	Bioreactors for screening and bioprocess development	-	FIDURA, S-UBG & 4 others	38/100
7th	Engineering for All 2016, Yokneam Illit (Israel), Series A	Provider of point of care diagnostic device	$7.4M	eHealth Ventures, Innovation Israel & 5 others	38/100
8th	Beijing Zhizhen Biotechnology 2017, Beijing (China), Series B	Provider of hematology testing instruments, reagents, and services	$17.8M	Fortune Capital, Shanghai Shengyu Equity Investment Fund Management ... & 8 others	38/100
9th	Amino 2015, Toronto (Canada), Seed	Provider of lab equipment for bacterial transformations and culture growth	$250K	IndieBio, SOSV & 2 others	35/100
10th	CIMON Medical 2018, Trondheim (Norway), Seed	Developer of a patented device for monitoring blood flow for early diagnosis	$6.81M	ProVenture, Farvatn Venture & 5 others	35/100